Campylobacter jejuni is a leading cause of foodborne infection due to its ability to asymptomatically colonize agricultural animals. In addition to its prevalence, Campylobacter is becoming increasingly resistant to the clinical antibiotics, azithromycin and ciprofloxacin. As a result, public health agencies have identified drug resistant Campylobacter as a serious threat to public health and have suggested combating the pathogen at the farm-level by reducing its burden within agricultural animal reservoirs.
Due to antibiotic restrictions in agricultural animals, reducing Campylobacter burden on the farm requires the identification and development of novel approaches. To this end, our group employed a broad sampling strategy to isolate a diverse collection of bacteriophages that can predate Campylobacter. We successfully isolated 70 bacteriophages from these samples and subjected them to whole-genome sequencing and initial comparative genomic analysis. Following this analysis, we performed doseresponse assays by adding increasing concentrations of bacteriophage to C. jejuni cultures. From this work, we were able to identify diverse phage groups from multiple sources that correlated with robust inhibition of C. jejuni growth. Lastly, we employed transmission electron microscopy to examine the morphology of these bacteriophages and were able to confirm that genetic diversity reflected morphological diversity in these bacteriophages.
Importance
Globally, Campylobacter jejuni is the most common cause of bacterial-derived gastroenteritis due to its ability to colonize agriculturally relevant animals. The increasing prevalence of antibiotic resistant C. jejuni strains necessitates the development of novel treatments to combat colonization of the animal host. In this study, we describe the isolation of 70 bacteriophages from various environmental sources that infect and kill C. jejuni. A robust analysis of the genetic diversity of these phage is described, and transmission electron microscopy is utilized to evaluate morphological differences. This study describes a novel prospecting strategy for
Introduction
Campylobacter jejuni is a leading cause of bacterial-derived gastroenteritis in both the developed and developing world. In the developed world, the bacterium is thought to most often infect humans following the consumption of undercooked poultry, especially chickens, primarily due to the bacterium's ability to commensally reside within the avian gastrointestinal tract. Following ingestion, Campylobacter adheres to and invades epithelial cells lining the gastrointestinal tract, causing a potent inflammatory response that typically results in moderate to severe diarrhea, fever, and abdominal cramps (1) (2) (3) . While most infections in the developed world are self-limiting, and patients often recover without treatment, there are several post-infectious disorders that can complicate recovery, including septicemia, Guillain-Barré Syndrome (GBS), irritable bowel syndrome (IBS), and reactive arthritis (RA) (4) . In addition to the prevalence and severity of these infections, the extensive use of antibiotics in agriculture and human medicine is responsible for an emergence of antibiotic-resistant Campylobacter (5).
Thus, the Centers for Disease Control and Prevention (CDC) has designated antibiotic-resistant Campylobacter as a 'serious threat' to public health in the United States (6) .
Taken together, these observations indicate that the development of novel antimicrobials for the reduction or treatment of human Campylobacter infections is necessary (7) . Several avenues of reducing the incidence of human campylobacteriosis have been pursued at various levels of the infectious cycle (3). As mentioned above, in the developed world, the most common infection source in humans is undercooked poultry.
Thus, a large amount of research has centered on preventing contamination of food by reducing the pre-harvest burden of Campylobacter in poultry flocks (8) . Some of this research includes the identification and initial development of bacteriocins, bacteriophage, natural products, probiotics, small molecule inhibitors, and vaccines (3).
While some of these studies demonstrated modest reductions of C. jejuni numbers in small chicken cohorts, none have accomplished widespread implementation at the farm level.
As mentioned above, using bacteriophage at the farm-level to reduce Campylobacter numbers in poultry and decrease transmission to the food chain is an intervention that has been proposed by us and others (8) (9) (10) (11) . Bacteriophage are infectious agents of bacteria, ubiquitous in the environment where the host bacterium resides, and hold potential to be developed into antimicrobial treatments. Historically, bacteriophages were pursued as treatments for human infections in Europe and Asia (8) , while the United States invested heavily in the identification and development of antibiotics. With the emergence of antibiotic-resistant microorganisms, several research groups have begun to re-examine the efficacy of various bacteriophage at treating these resistant infections (8, (12) (13) (14) . Additionally, since phages often exhibit specificity for a particular bacterial host, treatment may be accomplished without impacting the normal microbiota, a feature that is becoming more appreciated in animal and human health.
As such, it is intriguing whether the earlier work to isolate Campylobacter-specific bacteriophage can be broadened and leveraged to develop treatments that reduce colonization of animal hosts, including chickens (8) . There is precedence for phage as a biocontrol treatment being commercially approved in the United States, and several phage-based biocontrol products have been approved for use on food (15) .
In previous studies, bacteriophages with anti-Campylobacter activity have been isolated from sewage, pig manure, poultry carcasses, and broiler chickens in Europe (8, 10, 11, (16) (17) (18) (19) . To increase the breadth and efficiency of anti-Campylobacter phage identification and characterization, we developed a phage prospecting pipeline for use in our studies. In this work, we describe the isolation of bacteriophage from multiple agricultural and environmental sources, including Campylobacter-free commercial chickens, which was confirmed via 16S rRNA gene analysis. Following phage purification, phage genomes were extracted from 70 phage suspensions and sequenced. From these sequencing runs, we were able to produce 58 de novo assemblies and determine the relative diversity of these phages using the Virus Classification and Tree-building Online Resource (VICTOR). Dose-response analyses of the phage suspensions were conducted and we were able to determine which group (determined by VICTOR) of bacteriophage correlated with the greatest inhibition of C. jejuni in vitro growth. Finally, transmission electron microscopy (TEM) was used to evaluate the morphology of bacteriophages isolated exhibiting the most potential to kill C. jejuni in vitro, leading to the identification of several unique anti-Campylobacter phage morphologies. The establishment of this phage prospecting pipeline will not only allow us to examine the diversity of anti-Campylobacter phage in each environment, but will also aid us in identifying those that hold potential as treatments for reducing Campylobacter colonization of animal hosts, including poultry, and/or human infections.
Results and discussion

Isolation and purification of bacteriophage from environmental samples
The following phage numbers were isolated and purified from environmental Fig. S1B and S1C ). Several other environmental samples yielded plaques, however, bacteriophage could not be consistently propagated from these samples during the purification steps.
Campylobacter cell counts
Campylobacter spp. counts from each sample are shown in 
Chicken microbiome evaluation via 16s rRNA analysis
Using a more sensitive method of identifying Campylobacter within the cecal contents of chickens, we characterized the microbiomes of 10 of the cecal contents harvested from the large processor by sequencing and analyzing the 16S rRNA genes present within each sample. Additionally, we analyzed the microbiomes of five chickens inoculated on the day-of-hatch with 10 6 CFU C. jejuni 81-176 (positive control). Another group of five chickens was mock-infected on the day-of-hatch with sterile PBS (negative control). Sequencing data was organized into operational taxonomic units (OTUs) using mothur (23) , and the summation of each order, family, or genus was calculated. The results from this are shown in Figure 1 and Table S1 (Supplemental data). As expected, chickens infected on day-of-hatch with C. jejuni 81-176 yielded 16S rRNA sequences that corresponded to the microorganism when the cecum was harvested 7 days postinfection. The chickens that were mock-infected with PBS had a microbiota very similar to that of the infected birds, but did not contain sufficient Campylobacter sequences at the time of harvest. Similarly, the cecal samples from chickens at the large processor did not have sufficient Campylobacter sequences detected.
As expected, the mock-infected and Campylobacter-infected chickens that were hatched from specific pathogen-free eggs and raised in-house had a much less diverse cecal microbiome when compared to the chickens harvested from the processor that Another possible cause of the bacteriophage occurring in chicken ceca that do not harbor C. jejuni is that there is an alternate bacterial host. Most studies consider a bacteriophage host range to be broad when it infects multiple strains within a single species. However, measuring host range is dependent on the techniques used (i.e. spot testing, plaquing, etc.) and the growth conditions (e.g., incubation, temperature, and growth media) used for determination (27), making it difficult to compare host range results from different studies. To the best of our knowledge, no bacteriophage with antiCampylobacter activity have been isolated with a host range that extends beyond infection of closely related strains within the same species. Investigating the efficacy of the bacteriophage described in this study against a broad range of Campylobacter and closely related species is a future direction of this work.
Dose-response assays to screen bacteriophage for anti-Campylobacter potency
Ten-fold serial dilutions (1 -10 6 ) of each bacteriophage isolated from this study were screened for their ability to inhibit C. jejuni 81-176 growth in a 96-well microplate format. The percent growth of C. jejuni 81-176 at the bacteriophage titer (PFU) where growth was inhibited by at least 50% (IC50) is shown in Figure 2 . These assays indicated the phage strains exhibited a broad spectrum of activity against C. jejuni 81-
176. Approximately 22% of the phages yielded an IC50 of 1 PFU, 22% exhibited an IC50 of 10 PFU, 22% had an IC50 between 10 2 and 10 6 PFU, and 32% did not inhibit
Campylobacter growth.
Bacteriophages were isolated in this study from environmental samples that varied in temperature from ambient (temperature of the environment at the time of collection) to 42°C (chicken body temperature). For dose-response analysis, we chose to conduct the assays at 37°C for three reasons: i) there was concern that phage isolated from an ambient environment could not be propagated at 42°C, ii) previous studies have used 37°C for bacteriophage propagation (28, 29) , and iii) a future goal of this work is to develop the phages for treatment of Campylobacter colonization in animals other than chickens, including humans. A future direction of this study is to screen the most promising phages and screen them against a panel of Campylobacter strains at 42°C to determine which phages have potential to be developed into a biocontrol treatment for inhibiting Campylobacter colonization in chickens. Another future direction is to determine the phage receptor recognized by these bacteriophages.
Typically, bacteriophage that infect C. jejuni use capsular polysaccharides (CPS) or flagella as binding receptors (9) . Since C. jejuni strains utilize phase variation (PV) to create phenotypic heterogeneity of phage receptors and become resistant to phage (30) , it may be necessary to use a cocktail of phages that bind different receptors to maintain reduction of C. jejuni colonization in animal hosts.
Determination of bacteriophage diversity
Bacteriophage genetic diversity was visualized using phylogenomic Genome BLAST Distance Phylogeny (GBDP) trees (31) of bacteriophage assemblies that were generated in this study and two previously characterized phages, CP220 and CPt10 (32) . The accession numbers for these bacteriophage assemblies are listed in Table 2 .
The OPTSIL clustering program (33) yielded 38 species, 12 genera, and 5 families as defined by VICTOR ( Figure 3 ). The color that phage isolates are highlighted in Figure 3 correspond to their efficacy at killing C. jejuni as determined by dose response assays.
Hereafter, phage will be described by this color.
Phage distribution based on Clade clustering, as determined by VICTOR (VICTOR refers to Clades as Families), and isolation source of the phage, categorized by the color that indicates their efficacy at killing C. jejuni 81-176, is shown in Figure 4 .
Categories that had less than 3 phage isolates are not included in the figure. There was one highly potent (indicated as green) and one non-potent (indicated as red) phage clustered in Clade 1, and both phages were isolated from chickens at the large processor. There was one red phage clustered in Clade 2 and it was isolated from a chicken on a small farm. The majority of phages clustered in Clade 3 were green phage (61.3%), and 16 of these phages were isolated from the large processor, 1 from the small farm, 12 from untreated wastewater, and 2 from treated, non-disinfected wastewater ( Figure 4A ). There were more red phages (41.7%) clustered in Clade 4 than moderately potent (indicated as yellow) or green phage ( Figure 4B ). Twenty-two of these bacteriophages were isolated from the large processor, 1 from untreated wastewater, and 1 from pig feces. CP220 and CPt10 were clustered into Clade 5.
These results suggest that bacteriophage from Clade 3 have a higher probability of exhibiting robust anti-Campylobacter activity compared to the other Clades and that the phage belonging to this Clade were primarily isolated from large flocks or wastewater. Since a majority of phage clustered into Clade 4 also occurred in large flocks, but were generally not as effective at killing C. jejuni as Clade 3 phage, it will be important to distinguish these phages from those in Clade 3 in subsequent prospecting.
Clade 1 and Clade 2 only had 3 total bacteriophages isolated, thus more isolates would need to be evaluated to make a stronger conclusion regarding phages from these Clades.
From a source perspective, the majority of phages isolated from untreated wastewater were categorized as highly potent (76.9%) ( Figure 4C ). The categories of phage isolated from chickens in large flocks were fairly evenly distributed (27.5 -37.5%) ( Figure 4D ). One yellow phage and one red phage were isolated from small farm chickens; one green phage and one yellow phage were isolated from treated, disinfected wastewater; and one red phage was isolated from pig feces. These results suggest that bacteriophages isolated from untreated wastewater are more likely to exhibit a potent activity against C. jejuni compared to phages isolated from the other environments investigated in this study. These results also indicate that bacteriophage diversity is greatest in chickens in large flocks and that some are potent inhibitors of C.
jejuni growth. This suggests that in further phage prospecting, it will be more efficient to focus on samples from human wastewater and large chicken flocks.
CP220 and CPt10, two previously sequenced Campylobacter bacteriophages (32) , were compared to the phage isolated in this study. These two phages are closely related and are members of the class II Campylobacter Myoviridae phages. Of the over 200 bacteriophages isolated in previous studies that have been previously shown to infect C. jejuni or C. coli, the majority belong to the Myoviridae family, although 10 have been isolated that belong to the Siphoviridae family (34) . Based on the comparative genomic analysis performed using VICTOR, the phages isolated in this study belong to four different Clades, and none are in the same Clade as CP220 and CPt10. Thus, a future direction of this study is to conduct a more robust genomic analysis to further classify these phages, and other previously sequenced bacteriophages that infect
Campylobacter, which will allow for a more precise taxonomic classification.
Transmission electron microscopy
Several bacteriophages isolated in this study were observed via TEM (Fig. 5 ).
These images allowed us to correlate the morphology of the phages with the genetic classifications determined by VICTOR. Phage C13 (Fig. 5A ) and Phage A126 (Fig. 5B) belong to the same Clade. Phage A136 (Fig. 5C ) is in a different Clade than the other phages in Figure 5 . As indicated by the clustering and observed in the images, phages C13 and A126 have icosahedral heads, C13 has a flexible tail, and A126 has a rigid tail.
A136 has an icosahedral head and flexible tail. The morphological diversity between the imaged phages was reflected in the genomic diversity observed using VICTOR;
providing support to the reliability of this online resource. As with the comparative genomic analysis above, a future direction of this study is to ascertain which morphologies (e.g. features) correlate with the greatest inhibition of Campylobacter growth. We postulate the phage prospecting strategy described in this study will streamline future phage identification and development as we will be able to quickly determine which phages, from a genomic and morphological perspective, are likely most efficacious as Campylobacter treatments.
Conclusion
In this study, we describe a pipeline for isolating bacteriophages from various environments that can infect C. jejuni and inhibit in vitro growth. The majority of previous studies that isolated C. jejuni phages, only isolated from chickens, which may be disadvantageous as a prospecting strategy. We hypothesized that other environments may have a higher probability of containing potent phages that can successfully reduce
Campylobacter colonization of animals. We demonstrated that the bacteriophages isolated in this study exhibited a spectrum of activity against C. jejuni 81-176 in vitro.
Further, we were able to attribute the highest levels of activity to large flocks and human wastewater sources, which contained diverse phages from a genomic and morphological perspective.
A future direction of this work is to study the most effective anti-Campylobacter phages in bioreactor systems that mimic the gastrointestinal environment and animal model systems, including chickens. In order to become a feasible pre-harvest biocontrol treatment, bacteriophage must survive ingestion by the animal, survive enteric defense systems, and bind specifically to the bacterium with minimal non-specific binding to intestinal components. Finally, the bacteriophage must be able to infect Campylobacter and replicate in the gastrointestinal tract (35) . Due to the current prevalence of antibiotic resistant C. jejuni strains, novel strategies (i.e. phage as a biocontrol treatment) must be developed to decrease the rate of infection from agricultural animals. Additionally, the development of phage therapies may be attractive alternatives for treating
Campylobacter infection in patients in the developing world since they are relatively cheap to produce, spare the commensal microbiota (particularly important for malnourished and immunocompromised patients), and can be dry powder formulated so that no refrigeration is necessary (36) . The ability to eliminate Campylobacter in a specific manner is particularly important in developing nations since the gastrointestinal dysbiosis caused by traditional antibiotics puts patients at a further disadvantage for digestion and nutrient acquisition (3, 37) . We postulate bacteriophages that infect and kill Campylobacter have the potential to be developed into treatments, but further development and investigation is necessary.
Materials and methods
Microbial strains, maintenance, and culture conditions
C. jejuni 81-176 has been described in previous studies (38, 39) . For long term storage, the strain was stored at -80°C in Mueller-Hinton (MH) broth and 20% glycerol.
Inoculum for the experiments described below was grown on MH agar with 10 µg/mL trimethoprim and incubated for 48 hours at 37°C in microaerobic conditions (85% N 2 , 10% CO 2 , 5% O 2 ). To suspend the bacteria in liquid media, 1 mL of MH broth was added to the agar plates containing C. jejuni and a sterile inoculating loop was used to thoroughly mix the inoculum. This inoculum was then transferred to sterile 15 mL conical tubes containing 14 mL MH broth for use in the experiments described below.
Isolation and purification of bacteriophage from environmental samples
To isolate bacteriophage from the environment, liquid samples were collected from two human wastewater facilities. After incubation, the cultures were filter sterilized as described above to remove C. jejuni cells and 100 µL aliquots from this sample were serially diluted in 900 µL SM buffer (10 -2 -10 -8 dilutions) in 96-deep well plates. Ten µL aliquots of each dilution were spotted onto a MH top agar plate embedded with C. jejuni 81-176 (described above) and plates were incubated for 24 hours at 37°C in microaerobic conditions (85% N 2 , 10% CO 2 , 5% O 2 ). After 24 hours of incubation, the plates were examined for the presence of zones of clearing, indicating bacterial lysis from phage. The dilution yielding zones of clearing was then embedded in an agar embedded C. jejuni culture and incubated for 24 hours at 37°C in microaerobic conditions. After 24 hours, individual plaques could be observed in the agar embedded C. jejuni culture. A blunt-end pipet was used to excise the agar plug containing the plaque and was transferred to a 1.5 mL microcentrifuge tube containing 1 mL SM buffer; this was incubated at 4°C on a gyratory platform shaker at 15 rpm for ~24 h. To ensure that samples contained individual phage strains and not a mixture, two subsequent propagation and plaque isolation steps were performed as described above. After the third plaque isolation and purification, the purified phage isolate was enriched in MH broth with C. jejuni 81-176 as described above and phage titers were determined. If there was greater than 10 7 PFU/mL, the concentrated phage isolate was stored long-term in SM buffer at 4°C as described above.
Campylobacter cell counts
To enumerate Campylobacter from the agricultural and environmental samples that were evaluated for phage, samples were serially diluted (1:10) in sterile phosphatebuffered saline (PBS). Dilutions (100 µL) were plated on Campylobacter-specific (CS) media (MH agar with 10% defibrinated sheep blood containing 100 µg/mL cyclohexamide, 100 µg/mL vancomycin, 40 µg/mL cefoperazone, and 10 µg/mL trimethoprim) and incubated until countable colonies were present (~48 hours) in microaerobic conditions (85% N 2 , 10% CO 2 , 5% O 2 ).
Chicken microbiome evaluation via 16S rRNA analysis
To evaluate the cecal microbiome of chickens harvested from large flocks at a processor, a randomized block design was used. Using the random number generator function of the Simetar add-in for Microsoft Excel (40), 10 chickens were chosen from each of two collection dates at the processor (the chickens from the first collection date originated from one farm, and the chickens from the second collection date originated from another farm). Cecal microbiomes of five chickens infected with C. jejuni (positive control) and five chickens mock infected with PBS (negative control) were also evaluated.
To infect chickens for microbiome analysis, the day-of-hatch chicken model was used, as previously described, with modifications (41). To prepare the inoculum, C.
jejuni was cultivated and transferred to a 15-mL conical as described in Section 2.1, but PBS rather than MH broth was used as a diluent. From this, a suspension of 10 7 CFU/mL C. jejuni 81-176 was made in sterile PBS and used to inoculate day-of-hatch white leghorn chicks (Charles River, Wilmington, MA, USA) by oral gavage with 10 6 CFU C. jejuni (100 µL of suspension). Cecal contents were harvested seven days' postinfection, serially diluted (1:10) in PBS, and plated to enumerate C. jejuni. The remaining cecal contents were stored at -80°C. This chicken protocol was reviewed and approved by the University of Tennessee Institutional Animal Care and Use Committee (protocol #2493).
To extract bacterial DNA from the stored cecal contents, the DNeasy PowerSoil Kit was used (MO BIO Laboratories, Carlsbad, CA, USA). For 16S rRNA gene sequencing, Illumina's 16s metagenomic sequencing library protocol was utilized per the manufacturer's instructions (42) . The V3 -V4 hypervariable region of the 16S rRNA gene was sequenced using the Illumina MiSeq platform and the data was analyzed with the bioinformatics software, mothur, using the MiSeq SOP (23) . The cutoff point for minimum representation of genus, family, or order was 10 sequences. Thus, any microorganisms with ≤10 sequences detected were omitted from the dataset.
Dose-response assays to screen bacteriophage for anti-Campylobacter potency
The efficacy of each bacteriophage isolate at inhibiting C. jejuni growth was evaluated via dose-response assays. First, phage stocks were each normalized to a specific titer prior to dilution. Next, 10-fold serial dilutions (1 -10 6 ) of bacteriophage were combined in MH broth with C. jejuni 81-176 (OD 600 0.025) in a 96-well microplate and incubated at 37°C in microaerobic conditions (85% N 2 , 10% CO 2 , 5% O 2 ). C. jejuni growth was monitored daily via absorbance (OD 600 ) in a microplate reader. These trials concluded once bacterial growth reached stationary phase (~70 h). IC50 values were determined for each phage isolate at daily time points using regression analysis in GraphPad Prism 7.
Determination of bacteriophage diversity
To obtain enough phage DNA to sequence, phages were propagated as described above, enriched using C. jejuni 81-176. Prior to phage capsid lysis, bacterial DNA was treated with 20 U RNAse-free DNase I (Ambion, Inc., Austin, TX, USA), incubated for 15 min at room temperature, and inactivated at 75°C for 5 min, to allow for specific enrichment of phage DNA. Bacteriophage DNA was then isolated and purified using a phage DNA isolation kit (Norgen Biotek Corp., Ontario, Canada). This DNA was submitted to the Center for Genomics and Bioinformatics at Indiana University for library preparation and Illumina NextSeq 150 (mid output) sequencing using paired-end reads.
Next, bacteriophage genomes were assembled de novo using the sequencing analysis software, Geneious R10 (Biomatters, Auckland, New Zealand). To eliminate C. jejuni host sequences, all reads were mapped to the C. jejuni 81-176 reference genome (CP000538) and aligned reads were discarded from the dataset prior to assembly.
Sequences were mapped using the Geneious Mapper function, with medium sensitivity, iterated up to 5 times. Next, the unused reads were assembled using the Geneious assembler with medium-low sensitivity. Then, the ORF finder function was used to identify putative ORFs, and protein sequences were analyzed via BLASTp to confirm assembled contigs were bacteriophage genomes Identified phage genomes were clustered into phylogenetic clustering of the shared regions of these phages using VICTOR (43) . VICTOR performs pairwise comparisons of phage nucleotide sequences using the (GBDP) approach (44) and the settings recommended for prokaryotic viruses (43) . The resulting intergenomic distances (100 replicates each) were used to infer a balanced minimum evolution tree with branch support from FASTME and SPR post-processing for the D0 formula (31) .
The phylogenetic trees were rooted at the midpoint (45) and constructed by FigTree (46) . Species, genus, and family level taxon boundaries were estimated by the OPTSIL program (33), recommended clustering thresholds (43) , and an F value (fraction of links needed for cluster fusion) of 0.5 (47).
Transmission electron microscopy
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